Leading experts discuss the pros and cons of government regulations and explain how they affect everyday life for Americans.
April 21, 2023
The European Union is considering adopting a wide-ranging regulatory regime for the licensing and litigation of standard essential patents (SEPs). This panel of experts will discuss the EU proposal and its implications for participation in standards development, patent law, commercial law, competition law and innovation policy in the global innovation economy.
Learn moreApril 13, 2023
What statutes and regulations apply to AI, and do the existing legal and regulatory frameworks concerning anti-discrimination in labor and employment suffice to address the novel nature of AI?
Learn moreApril 13, 2023
At an in-person luncheon, EEOC Commissioner Keith Sonderling delivered a keynote address on issues concerning AI’s entrance into the Labor and Employment space.
Learn moreApril 10, 2023
What statutes and regulations apply to AI, and do the existing legal and regulatory frameworks concerning anti-discrimination in labor and employment suffice to address the novel nature of AI?
Learn moreApril 3, 2023
An expert panel discusses the origins as well as the potential benefits and risks of this innovation in government contracting policy.
Learn moreMarch 9, 2023
A panel of experts discussed what Section 230 permits and doesn’t permit—a question now before a number of courts, including the U.S. Supreme Court in Gonzalez v. Google.
Learn moreMarch 8, 2023
Recent months have seen a flurry of notable developments at the Federal Trade Commission. Antitrust law experts examine these developments and debate what might come next at the FTC.
Learn moreMarch 8, 2023
In January 2023, the FTC announced a proposed rule that would ban noncompete agreements across most of the U.S. economy – a move President Biden lauded in his recent State of the Union address.
Learn moreFebruary 17, 2023
With a string of cryptocurrency failures and tens of billions in losses for investors, increased regulation has become a hot topic.
Learn moreFebruary 16, 2023
In November 2022, the Alliance Defending Freedom (ADF) filed a federal lawsuit in the U.S. District Court for the Northern District of Texas, Amarillo Division, against the United States Food and Drug Administration (FDA) on behalf of the Alliance of Hippocratic Medicine (AHM) and others.
Learn more